Tagged With GILD

Immunomedics soars 106% after Gilead agrees to acquire the cancer-drug company for $21 billion

2 biotech stocks plummet more than 25% after the FDA rejects their drug applications

Gilead soars 11% after reporting positive news on potential coronavirus treatment

US stocks close mixed as virus drug report offsets oil-market surge

Gilead tanks 9% on report its coronavirus drug doesn't help patients

Arcus Biosciences spikes 99% on reports of $10 billion Gilead partnership

One Wall Street firm says approval for Gilead's experimental coronavirus treatment is a coin-flip bet at best — but still thinks you should buy the stock right now

A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.

Drug developer Gilead soars to 16-month high after WHO official says its experimental treatment is best shot for fighting coronavirus